Takojantie 18
70900 Toivala
Finland
Phone: +358 17 3688500
Fax: +358 17 3688530
http://www.reagena.fi
info@reagena.fi
Manufacturers
OEM
Company Contacts
Department/ Name Address
Reagena Ltd. Mr. Mikko Regina, MSc, Business Development Manager, Reagena Ltd, Takojantie 18, 70900 Toivala
mikko.regina@reagena.fi
Reagena Ltd. Mr. Markku Parviainen, PhD,eMBA, CEO, Reagena Ltd, Takojantie 18, 70900 Toivala
markku.parviainen@reagena.fi
Reagena Ltd. Mr.Ilpo Kuronen, PhD, R&D Director, Reagena Ltd, Takojantie 18, 70900 Toivala
ilpo.kuronen@reagena.fi
Company Figures
Number of employees 20-49
Sales volume 1-9 Mio US $
Export content max. 25%
Year of foundation 1993
Area of business Diagnostics
Company Profile
Reagena Ltd “Visible Difference”
REAGENA Ltd is a health care technology provider. REAGENA focuses on areas of unmet needs in Point-of-Care (POC) diagnostics of infectious disease and immunity.
We offer value to our customers in
• Manufacturing of ready-to-use test kits
• Developing diagnostic tests for laboratory medicine
• Point-of-care testing (R&D, manufacturing, commercialisation of innovations)
We commit to high quality, and on understanding our customers´ needs. Our certified ISO 9001:2000 and ISO 13485:2003 Quality Systems cover all of our activities, and provide a solid basis for continuous development of quality. Our IVD products are CE-marked (IVDD 98/79/EC).
Along with the high quality products we also are engaged in contract development and production for other industries.
Product portfolio
REAGENA offers Rapid Test System which is based on ReaScan™ reader together with ReaLink™ Bluetooth wireless technology and ReaMobile™ software, and our proprietary immuno-chromatography technology. Alternatively, the data can be transferred via cable to ReaMobile™ Software on PC. The ReaScan™ Rapid Test System is versatile for quantitative and qualitative applications in clinical chemistry, virology, and microbiology.
The ReaScan™ Rapid Test System is designed to provide diagnostic results quickly and easily. Quantitative diagnostic results are displayed and printed in easy to read numbers. Qualitative diagnostic panel results are displayed as positive or negative, eliminating the need for interpretation of lines that often hamper qualitative diagnostics.
The first launched tests included REASCAN™ Puumala -IgM, REASCAN™ CRP and REASCAN™ hs-CRP and now we are launching throat swab bacterial antigen test, REASCAN™ Strep A. These tests are ideal for small health care units and laboratories with minimum training.
In addition to the rapid tests, Reagena Ltd recently introduced a fast and flexible EIA assay format for diagnosis of acute virus infections. REAGENA Puumala IgM and IgG EIA are the first products of this line.
Our product range for diagnosis of acute Hantavirus infections causing HFRS and HPS represents a good example of our efforts and dedication to introduce new products for rare viral infections. These diseases are usually poorly recognised by the physicians. The Reagena’s serodiagnostic tests use recombinant viral proteins of different Hantavirus serotypes as antigens.
The tests are easy-to-use and have high diagnostic reliability.
Strong impact on R&D
We are committed to development, production and marketing of novel innovative diagnostics. Proven examples of these are POC tests for acute Hantavirus infections and immunity.
Strong Impact on R&D
We work on close collaboration with leading universities and research institutes in several countries to develop technologies and reagents for rapid diagnostics.
Oy Reagena Ltd
Takojantie 18, FIN-70900 Toivala, Finland
Tel. +358 17 3688 500 Fax +358 17 3688 530
info@reagena.fi
www.reagena.fi